Company Filing History:
Years Active: 2018
Title: Fabrice Cornille: Innovator in Pharmaceutical Synthesis
Introduction
Fabrice Cornille is a notable inventor based in Bures sur Yvette, France. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of active ingredients for medical applications. With a total of 2 patents to his name, Cornille's work is focused on addressing both common and rare diseases.
Latest Patents
Cornille's latest patents include a process for preparing D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide. This invention relates to a solution-phase synthesis of the compound, which serves as an active ingredient in therapies targeting ischemia reperfusion injury. His second patent also pertains to the production of the same compound, emphasizing its importance in medical treatments.
Career Highlights
Fabrice Cornille is associated with Flamma S.p.a., a company known for its commitment to pharmaceutical innovation. His work at Flamma has allowed him to explore advanced synthesis techniques that contribute to the development of effective therapeutic agents.
Collaborations
Cornille has collaborated with talented coworkers, including Xinjun Zhao and Minyu Zheng. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Fabrice Cornille's contributions to pharmaceutical synthesis demonstrate his commitment to advancing medical science. His innovative patents reflect a dedication to improving therapies for various diseases.